Association of Frailty and Long-Term Survival in Patients Undergoing Coronary Artery Bypass Grafting

Diem T T Tran1,2, Jack V Tu3,4, Jean-Yves Dupuis1

  • 1Division of Cardiac Anesthesiology, Department of Anesthesiology and Pain Medicine, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Insights

Frailty is common in cardiac surgery patients and increases long-term mortality risk. Younger frail patients (<75 years) may benefit most from prehabilitation programs.

Area of Science:

  • Gerontology
  • Cardiology
  • Public Health

Background:

  • Frailty is a growing concern in clinical practice, particularly in cardiac surgery.
  • Existing research on frailty in cardiac surgery is limited by small sample sizes and short follow-up periods.
  • Epidemiological data on frailty in long-term cardiac surgery outcomes are lacking.

Purpose of the Study:

  • To investigate the prevalence and long-term mortality implications of frailty in a large cohort of cardiac surgery patients.
  • To examine the association between frailty and mortality over an extended follow-up period.
  • To identify specific age groups that may benefit from targeted interventions.

Main Methods:

  • A population-based, retrospective cohort study was conducted in Ontario, Canada (2008-2015).
  • Frailty was assessed using the Johns Hopkins Adjusted Clinical Groups (ACG) frailty indicator.
  • Mortality was analyzed using Kaplan-Meier curves and multivariable Cox proportional hazard models.

Main Results:

  • Out of 40,083 patients, 8,803 (22%) were identified as frail.
  • Frail patients had a significantly higher long-term mortality rate (33 per 1000 person-years) compared to non-frail patients (22 per 1000 person-years).
  • Frailty was independently associated with a 20% increased risk of long-term mortality (aHR=1.20).

Conclusions:

  • Frailty is prevalent in coronary artery bypass grafting patients and independently predicts long-term mortality.
  • The risk of frailty-related death was inversely proportional to age, with younger patients (<75 years) showing a greater survival difference.
  • Enhanced preoperative risk stratification and optimization programs, including prehabilitation, are recommended for selected patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
500
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
289
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
399
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
722